Cargando…
New onset atrial fibrilation and risk faktors in COVID-19
BACKGROUND: There is limited data concerning the prevalence of arrhythmias, particularly atrial fibrillation (AF), which may develop as a consequence of direct myocardial injury and the inflammatory state existing in COVID-19. METHODS: This single-center study included data concerning 658 COVID-19 p...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825910/ https://www.ncbi.nlm.nih.gov/pubmed/33556739 http://dx.doi.org/10.1016/j.jelectrocard.2020.12.005 |
_version_ | 1783640419026862080 |
---|---|
author | Kelesoglu, Saban Yilmaz, Yucel Ozkan, Eyup Calapkorur, Bekir Gok, Mustafa Dursun, Zehra Bestepe Kilic, Aysegul Ulu Demirelli, Selami Simsek, Ziya Elcık, Deniz |
author_facet | Kelesoglu, Saban Yilmaz, Yucel Ozkan, Eyup Calapkorur, Bekir Gok, Mustafa Dursun, Zehra Bestepe Kilic, Aysegul Ulu Demirelli, Selami Simsek, Ziya Elcık, Deniz |
author_sort | Kelesoglu, Saban |
collection | PubMed |
description | BACKGROUND: There is limited data concerning the prevalence of arrhythmias, particularly atrial fibrillation (AF), which may develop as a consequence of direct myocardial injury and the inflammatory state existing in COVID-19. METHODS: This single-center study included data concerning 658 COVID-19 patients, who were hospitalized in our institute, between April 20th, 2020 and July 30th, 2020. Demographic data, findings of the imaging studies, and laboratory test results were retrieved from the institutional digital database. RESULTS: New onset AF (NOAF) was identified in 33 patients (5%). Patients who developed AF were older (72.42 ± 6.10 vs 53.78 ± 13.80, p < 0.001) and had higher frequencies of hypertension and heart failure compared to patients without NOAF (p < 0.001, for both). The CHA2DS2-VASc score was higher in patients, who developed NOAF, compared to those who did not during hospitalization for COVID-19 (p < 0.001). Subjects, who developed NOAF during hospitalization, had a higher leukocyte count, neutrophil / lymphocyte ratio (NLR), C-reactive protein, erythrocyte sedimentation rate, and procalcitonin levels compared to those without NOAF (p < 0.001 for all comparisons). Diffuse lung infiltration was also more frequent in COVID-19 patients, who developed NOAF, during hospitalization (p = 0.015). Multivariate logistic regression analysis demonstrated that age, CHA2DS2-VASc score, CRP, erythrocyte sedimentation rate, and presence of diffuse lung infiltration on thorax CT were predictive for NOAF. CONCLUSION: The prevalence of NOAF in hospitalized COVID-19 patients is higher than the general population. Age, CHA2DS2-VASc score, C-reactive protein, erythrocyte sedimentation rate, and presence of diffuse lung infiltration on thorax CT may be used to identify patients at high risk for development of NOAF. Especially among these parameters, the presence of diffuse lung infiltration on thorax CT it was the most powerful independent predictor of NOAF development. |
format | Online Article Text |
id | pubmed-7825910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78259102021-01-25 New onset atrial fibrilation and risk faktors in COVID-19 Kelesoglu, Saban Yilmaz, Yucel Ozkan, Eyup Calapkorur, Bekir Gok, Mustafa Dursun, Zehra Bestepe Kilic, Aysegul Ulu Demirelli, Selami Simsek, Ziya Elcık, Deniz J Electrocardiol Article BACKGROUND: There is limited data concerning the prevalence of arrhythmias, particularly atrial fibrillation (AF), which may develop as a consequence of direct myocardial injury and the inflammatory state existing in COVID-19. METHODS: This single-center study included data concerning 658 COVID-19 patients, who were hospitalized in our institute, between April 20th, 2020 and July 30th, 2020. Demographic data, findings of the imaging studies, and laboratory test results were retrieved from the institutional digital database. RESULTS: New onset AF (NOAF) was identified in 33 patients (5%). Patients who developed AF were older (72.42 ± 6.10 vs 53.78 ± 13.80, p < 0.001) and had higher frequencies of hypertension and heart failure compared to patients without NOAF (p < 0.001, for both). The CHA2DS2-VASc score was higher in patients, who developed NOAF, compared to those who did not during hospitalization for COVID-19 (p < 0.001). Subjects, who developed NOAF during hospitalization, had a higher leukocyte count, neutrophil / lymphocyte ratio (NLR), C-reactive protein, erythrocyte sedimentation rate, and procalcitonin levels compared to those without NOAF (p < 0.001 for all comparisons). Diffuse lung infiltration was also more frequent in COVID-19 patients, who developed NOAF, during hospitalization (p = 0.015). Multivariate logistic regression analysis demonstrated that age, CHA2DS2-VASc score, CRP, erythrocyte sedimentation rate, and presence of diffuse lung infiltration on thorax CT were predictive for NOAF. CONCLUSION: The prevalence of NOAF in hospitalized COVID-19 patients is higher than the general population. Age, CHA2DS2-VASc score, C-reactive protein, erythrocyte sedimentation rate, and presence of diffuse lung infiltration on thorax CT may be used to identify patients at high risk for development of NOAF. Especially among these parameters, the presence of diffuse lung infiltration on thorax CT it was the most powerful independent predictor of NOAF development. Elsevier Inc. 2021 2021-01-21 /pmc/articles/PMC7825910/ /pubmed/33556739 http://dx.doi.org/10.1016/j.jelectrocard.2020.12.005 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kelesoglu, Saban Yilmaz, Yucel Ozkan, Eyup Calapkorur, Bekir Gok, Mustafa Dursun, Zehra Bestepe Kilic, Aysegul Ulu Demirelli, Selami Simsek, Ziya Elcık, Deniz New onset atrial fibrilation and risk faktors in COVID-19 |
title | New onset atrial fibrilation and risk faktors in COVID-19 |
title_full | New onset atrial fibrilation and risk faktors in COVID-19 |
title_fullStr | New onset atrial fibrilation and risk faktors in COVID-19 |
title_full_unstemmed | New onset atrial fibrilation and risk faktors in COVID-19 |
title_short | New onset atrial fibrilation and risk faktors in COVID-19 |
title_sort | new onset atrial fibrilation and risk faktors in covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825910/ https://www.ncbi.nlm.nih.gov/pubmed/33556739 http://dx.doi.org/10.1016/j.jelectrocard.2020.12.005 |
work_keys_str_mv | AT kelesoglusaban newonsetatrialfibrilationandriskfaktorsincovid19 AT yilmazyucel newonsetatrialfibrilationandriskfaktorsincovid19 AT ozkaneyup newonsetatrialfibrilationandriskfaktorsincovid19 AT calapkorurbekir newonsetatrialfibrilationandriskfaktorsincovid19 AT gokmustafa newonsetatrialfibrilationandriskfaktorsincovid19 AT dursunzehrabestepe newonsetatrialfibrilationandriskfaktorsincovid19 AT kilicaysegululu newonsetatrialfibrilationandriskfaktorsincovid19 AT demirelliselami newonsetatrialfibrilationandriskfaktorsincovid19 AT simsekziya newonsetatrialfibrilationandriskfaktorsincovid19 AT elcıkdeniz newonsetatrialfibrilationandriskfaktorsincovid19 |